Stakeholders Ask FDA For Clarity, Rule Cementing Data Systems Downgrade
This article was originally published in The Gray Sheet
Executive Summary
Industry representatives and patient advocacy groups say they support FDA’s decision to refrain from regulating medical device data systems but want further clarification and a rule to more explicitly state the agency’s intentions.